PLX:NYSEAMERICAN
Protalix Biotherapeutics Inc
$2.62
arrow_upward
+0.77%(+0.020) 1D
$2.62
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 3, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PLX...
Open
$2.59
High
$2.66
Low
$2.57
Mkt. cap
211.10M
Avg. vol.
723.79K
Volume
931.92K
P/E ratio
11.58
52-wk high
$3.19
52-wk low
$1.52
EPS
$0.23
Beta
0.02
Shares outstanding
80.57M
No. of employees
226
Open
$2.59
High
$2.66
Low
$2.57
Mkt. cap
211.10M
Avg. vol.
723.79K
Volume
931.92K
P/E ratio
11.58
52-wk high
$3.19
52-wk low
$1.52
EPS
$0.23
Beta
0.02
Shares outstanding
80.57M
No. of employees
226
Profile
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
About Protalix Biotherapeutics Inc
CEODror Bashan
Employees226
Founded1993
HeadquartersKarmiel, North District, Israel
SectorBiotechnology
Websiteprotalix.com